Cargando…

Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014

We characterized use of the carbapenems, polymyxins, and tigecycline in United States children’s hospitals between 2010 and 2014. We found substantial variability in use across hospitals and overall decreased use over time. Most polymyxin and tigecycline use occurred in cystic fibrosis patients, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiotos, Kathleen, Ross, Rachael K., Han, Jennifer H., Miller, Matthew, Gerber, Jeffrey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407215/ https://www.ncbi.nlm.nih.gov/pubmed/28470018 http://dx.doi.org/10.1093/ofid/ofx039

Ejemplares similares

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Tian, Yuan, et al.
Publicado: (2021)

Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin
por: Jin, Xi, et al.
Publicado: (2021)

Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005–2010
por: Huttner, Benedikt, et al.
Publicado: (2012)

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems
por: Karakonstantis, Stamatis, et al.
Publicado: (2020)

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
por: Chiotos, Kathleen, et al.
Publicado: (2018)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Liang, Qiqiang, et al.
Publicado: (2019)

Ceftazidime/Avibactam, Polymyxin or Tigecycline as a Rescue Strategy for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae in Bloodstream Infection: A Retrospective Cohort Study
por: Fang, Youling, et al.
Publicado: (2023)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Blastomycosis-Associated Hospitalizations, United States, 2010–2020
por: Benedict, Kaitlin, et al.
Publicado: (2023)

Walking to Work: Trends in the United States, 2005–2014
por: Yang, Yong
Publicado: (2016)

Trends in Health-Related Quality of Life Among Adolescents in the United States, 2001–2010
por: Cui, Wanjun, et al.
Publicado: (2013)

Epidemiologic and Microbiologic Characteristics of Hospitalized Patients Co-colonized With Multiple Species of Carbapenem-Resistant Enterobacteriaceae in the United States
por: Adediran, Timileyin, et al.
Publicado: (2020)

Use of polymyxins for carbapenem-resistant infections in children and adolescents
por: Barco-Cabrera, Carolina, et al.
Publicado: (2022)

Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016)

Trends in Legionnaires’ Disease-Associated Hospitalizations, United States, 2006–2010
por: Mudali, Gayathri, et al.
Publicado: (2020)

Emergence of Carbapenem- and Tigecycline-Resistant Proteus cibarius of Animal Origin
por: Li, Yan, et al.
Publicado: (2020)

Prevalence of and Trends in Diabetes Among Veterans, United States, 2005–2014
por: Liu, Ying, et al.
Publicado: (2017)

State-Specific Cessation Behaviors Among Adult Cigarette Smokers — United States, 2014–2015
por: Wang, Teresa W., et al.
Publicado: (2019)

RapidResa Polymyxin Acinetobacter NP(®) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
por: Bouvier, Maxime, et al.
Publicado: (2021)

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Hu, Guangxue, et al.
Publicado: (2022)

Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae
por: Jiang, Yuansu, et al.
Publicado: (2019)

Does procalcitonin have clinical utility in the management of paediatric community-acquired pneumonia? A PRO/CON debate
por: Chiotos, Kathleen, et al.
Publicado: (2021)

In Vitro Activity of Tigecycline Against Orientia tsutsugamushi
por: Lee, Sun-Myoung, et al.
Publicado: (2016)

Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study
por: Zha, Lei, et al.
Publicado: (2023)

681. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States Hospitals, 2010–2015
por: Echols, Roger, et al.
Publicado: (2018)

681. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States Hospitals, 2010–2015
por: Echols, Roger, et al.
Publicado: (2018)

Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms
por: Lu, Qiong, et al.
Publicado: (2021)

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
por: Guo, Wei, et al.
Publicado: (2018)

Suicide rates of migrants in United States immigration detention (2010–2020)
por: Erfani, Parsa, et al.
Publicado: (2021)

Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis
por: Oliveira, Priscila R., et al.
Publicado: (2020)

Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem‐resistant Klebsiella pneumoniae isolates
por: Park, Yumi, et al.
Publicado: (2020)

Comparative Evaluation of Seven Tigecycline Susceptibility Testing Methods for Carbapenem-Resistant Enterobacteriaceae
por: Li, Hongling, et al.
Publicado: (2021)

Genetic and virulence characteristics of a Raoultella planticola isolate resistant to carbapenem and tigecycline
por: Li, Ying, et al.
Publicado: (2022)

Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014
por: Gallaway, M. Shayne, et al.
Publicado: (2018)

Anemia Screening, Prevalence, and Treatment in Pediatric Inflammatory Bowel Disease in the United States, 2010–2014
por: Miller, Steven D., et al.
Publicado: (2019)

Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil
por: Bartolleti, Flávia, et al.
Publicado: (2016)

Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance
por: Bento Talizin, Thalita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jh74eh7bsf4ced0vspih73bip2